Alembic Pharmaceuticals Limited
₹1,028
INR+8.50(+0.83%)
As of November 14, 2024 10:00:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹21298.59 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹21265.99 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
33.79
Forward P/E
Price to Earnings ratio based on forecasted earnings
24.51
PEG Ratio
Price/Earnings to Growth ratio
24.51
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
3.38
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
74.77%
Operating Margin
Operating income as a percentage of revenue
10.74%
Return on Equity
Net income as a percentage of shareholders' equity
12.78%
Revenue (TTM)
Total revenue over trailing 12 months
₹6304.21 Cr+5.1%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹984.40 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹32.07+11.700000000000001%
Balance Sheet
Total Cash
Total cash and short-term investments
₹120.21 Cr
Total Debt
Total short-term and long-term debt
₹513.16 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
10.65%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹710.25 - ₹1303.9
Beta
Measure of stock's volatility compared to the market
0.69
Shares Outstanding
Total number of shares issued by the company
₹19.66 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
3.89%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
0.00%
Payout Ratio
Percentage of earnings paid as dividends
24.98%